Tazobactam prevention of emergence of resistance.
Neu
H C
HC
Department of Medicine, Columbia University, New York, New York 10032.
Niu
W W
WW
Chin
N X
NX
D001419:Bacteria / Q000187:drug effects* / Q000201:enzymology; D001441:Bacteroides fragilis / Q000187:drug effects / Q000201:enzymology; D004352:Drug Resistance, Microbial; D004926:Escherichia coli / Q000187:drug effects / Q000201:enzymology; D006801:Humans; D007711:Klebsiella pneumoniae / Q000187:drug effects / Q000201:enzymology; D010397:Penicillanic Acid / Q000494:pharmacology*; D010403:Penicillin Resistance; D010878:Piperacillin / Q000494:pharmacology; D013211:Staphylococcus aureus / Q000187:drug effects / Q000201:enzymology; D013212:Staphylococcus epidermidis / Q000187:drug effects / Q000201:enzymology; D000078142:Tazobactam; D065093:beta-Lactamase Inhibitors
D065093:beta-Lactamase Inhibitors; D010397:Penicillanic Acid; D000078142:Tazobactam; D010878:Piperacillin